カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の更年期ホルモン剤市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Menopause Hormonal Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23JU620）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23JU620
■ 発行日：2023年6月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆医療
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の更年期ホルモン剤市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の更年期ホルモン剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の更年期ホルモン剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 更年期ホルモン剤の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

更年期ホルモン剤市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・テーブル、ジェル、スプレー、その他

用途別セグメント
・病院薬局、小売薬局、オンライン薬局

主要な市場プレーヤー
・Merck、Novartis、Novo Nordisk、Pfizer、Allergan、Emcure Pharmaceuticals、Eli Lilly And Company、Bayer、Theramex、AbbVie

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、更年期ホルモン剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な更年期ホルモン剤メーカーの企業概要、2019年～2022年までの更年期ホルモン剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な更年期ホルモン剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別更年期ホルモン剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの更年期ホルモン剤のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での更年期ホルモン剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および更年期ホルモン剤の産業チェーンを掲載しています。
・第14、15章では、更年期ホルモン剤の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 更年期ホルモン剤の概要
- タイプ別分析（2018年vs2022年vs2029年）：テーブル、ジェル、スプレー、その他
- 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
- 世界の更年期ホルモン剤市場規模・予測
- 世界の更年期ホルモン剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Novartis、Novo Nordisk、Pfizer、Allergan、Emcure Pharmaceuticals、Eli Lilly And Company、Bayer、Theramex、AbbVie
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：テーブル、ジェル、スプレー、その他
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・更年期ホルモン剤の北米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・更年期ホルモン剤のヨーロッパ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・更年期ホルモン剤のアジア市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・更年期ホルモン剤の南米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・更年期ホルモン剤の中東・アフリカ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Menopause Hormonal Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Menopause Hormonal Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Menopause Hormonal Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Menopause Hormonal Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Menopause Hormonal Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Menopause Hormonal Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Novartis, Novo Nordisk, Pfizer and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Menopause Hormonal Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Table
Gel
Spray
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Merck
Novartis
Novo Nordisk
Pfizer
Allergan
Emcure Pharmaceuticals
Eli Lilly And Company
Bayer
Theramex
AbbVie
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Menopause Hormonal Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Menopause Hormonal Drug, with price, sales, revenue and global market share of Menopause Hormonal Drug from 2018 to 2023.
Chapter 3, the Menopause Hormonal Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Menopause Hormonal Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Menopause Hormonal Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Menopause Hormonal Drug.
Chapter 14 and 15, to describe Menopause Hormonal Drug sales channel, distributors, customers, research findings and conclusion.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Menopause Hormonal Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Menopause Hormonal Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Table
1.3.3 Gel
1.3.4 Spray
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Menopause Hormonal Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Menopause Hormonal Drug Market Size & Forecast
1.5.1 Global Menopause Hormonal Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Menopause Hormonal Drug Sales Quantity (2018-2029)
1.5.3 Global Menopause Hormonal Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Menopause Hormonal Drug Product and Services
2.1.4 Merck Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Menopause Hormonal Drug Product and Services
2.2.4 Novartis Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments/Updates
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business
2.3.3 Novo Nordisk Menopause Hormonal Drug Product and Services
2.3.4 Novo Nordisk Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Menopause Hormonal Drug Product and Services
2.4.4 Pfizer Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business
2.5.3 Allergan Menopause Hormonal Drug Product and Services
2.5.4 Allergan Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Allergan Recent Developments/Updates
2.6 Emcure Pharmaceuticals
2.6.1 Emcure Pharmaceuticals Details
2.6.2 Emcure Pharmaceuticals Major Business
2.6.3 Emcure Pharmaceuticals Menopause Hormonal Drug Product and Services
2.6.4 Emcure Pharmaceuticals Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Emcure Pharmaceuticals Recent Developments/Updates
2.7 Eli Lilly And Company
2.7.1 Eli Lilly And Company Details
2.7.2 Eli Lilly And Company Major Business
2.7.3 Eli Lilly And Company Menopause Hormonal Drug Product and Services
2.7.4 Eli Lilly And Company Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly And Company Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Menopause Hormonal Drug Product and Services
2.8.4 Bayer Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer Recent Developments/Updates
2.9 Theramex
2.9.1 Theramex Details
2.9.2 Theramex Major Business
2.9.3 Theramex Menopause Hormonal Drug Product and Services
2.9.4 Theramex Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Theramex Recent Developments/Updates
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business
2.10.3 AbbVie Menopause Hormonal Drug Product and Services
2.10.4 AbbVie Menopause Hormonal Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AbbVie Recent Developments/Updates
3 Competitive Environment: Menopause Hormonal Drug by Manufacturer
3.1 Global Menopause Hormonal Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Menopause Hormonal Drug Revenue by Manufacturer (2018-2023)
3.3 Global Menopause Hormonal Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Menopause Hormonal Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Menopause Hormonal Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Menopause Hormonal Drug Manufacturer Market Share in 2022
3.5 Menopause Hormonal Drug Market: Overall Company Footprint Analysis
3.5.1 Menopause Hormonal Drug Market: Region Footprint
3.5.2 Menopause Hormonal Drug Market: Company Product Type Footprint
3.5.3 Menopause Hormonal Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Menopause Hormonal Drug Market Size by Region
4.1.1 Global Menopause Hormonal Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Menopause Hormonal Drug Consumption Value by Region (2018-2029)
4.1.3 Global Menopause Hormonal Drug Average Price by Region (2018-2029)
4.2 North America Menopause Hormonal Drug Consumption Value (2018-2029)
4.3 Europe Menopause Hormonal Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Menopause Hormonal Drug Consumption Value (2018-2029)
4.5 South America Menopause Hormonal Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Menopause Hormonal Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
5.2 Global Menopause Hormonal Drug Consumption Value by Type (2018-2029)
5.3 Global Menopause Hormonal Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
6.2 Global Menopause Hormonal Drug Consumption Value by Application (2018-2029)
6.3 Global Menopause Hormonal Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
7.2 North America Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
7.3 North America Menopause Hormonal Drug Market Size by Country
7.3.1 North America Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Menopause Hormonal Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
8.2 Europe Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
8.3 Europe Menopause Hormonal Drug Market Size by Country
8.3.1 Europe Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Menopause Hormonal Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Menopause Hormonal Drug Market Size by Region
9.3.1 Asia-Pacific Menopause Hormonal Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Menopause Hormonal Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
10.2 South America Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
10.3 South America Menopause Hormonal Drug Market Size by Country
10.3.1 South America Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Menopause Hormonal Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Menopause Hormonal Drug Market Size by Country
11.3.1 Middle East & Africa Menopause Hormonal Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Menopause Hormonal Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Menopause Hormonal Drug Market Drivers
12.2 Menopause Hormonal Drug Market Restraints
12.3 Menopause Hormonal Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Menopause Hormonal Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Menopause Hormonal Drug
13.3 Menopause Hormonal Drug Production Process
13.4 Menopause Hormonal Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Menopause Hormonal Drug Typical Distributors
14.3 Menopause Hormonal Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Menopause Hormonal Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Menopause Hormonal Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Menopause Hormonal Drug Product and Services
Table 6. Merck Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Menopause Hormonal Drug Product and Services
Table 11. Novartis Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novartis Recent Developments/Updates
Table 13. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk Major Business
Table 15. Novo Nordisk Menopause Hormonal Drug Product and Services
Table 16. Novo Nordisk Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novo Nordisk Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Menopause Hormonal Drug Product and Services
Table 21. Pfizer Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Menopause Hormonal Drug Product and Services
Table 26. Allergan Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Allergan Recent Developments/Updates
Table 28. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Emcure Pharmaceuticals Major Business
Table 30. Emcure Pharmaceuticals Menopause Hormonal Drug Product and Services
Table 31. Emcure Pharmaceuticals Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Emcure Pharmaceuticals Recent Developments/Updates
Table 33. Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table 34. Eli Lilly And Company Major Business
Table 35. Eli Lilly And Company Menopause Hormonal Drug Product and Services
Table 36. Eli Lilly And Company Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Eli Lilly And Company Recent Developments/Updates
Table 38. Bayer Basic Information, Manufacturing Base and Competitors
Table 39. Bayer Major Business
Table 40. Bayer Menopause Hormonal Drug Product and Services
Table 41. Bayer Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bayer Recent Developments/Updates
Table 43. Theramex Basic Information, Manufacturing Base and Competitors
Table 44. Theramex Major Business
Table 45. Theramex Menopause Hormonal Drug Product and Services
Table 46. Theramex Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Theramex Recent Developments/Updates
Table 48. AbbVie Basic Information, Manufacturing Base and Competitors
Table 49. AbbVie Major Business
Table 50. AbbVie Menopause Hormonal Drug Product and Services
Table 51. AbbVie Menopause Hormonal Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AbbVie Recent Developments/Updates
Table 53. Global Menopause Hormonal Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Menopause Hormonal Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Menopause Hormonal Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Menopause Hormonal Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Menopause Hormonal Drug Production Site of Key Manufacturer
Table 58. Menopause Hormonal Drug Market: Company Product Type Footprint
Table 59. Menopause Hormonal Drug Market: Company Product Application Footprint
Table 60. Menopause Hormonal Drug New Market Entrants and Barriers to Market Entry
Table 61. Menopause Hormonal Drug Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Menopause Hormonal Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Menopause Hormonal Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Menopause Hormonal Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Menopause Hormonal Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Menopause Hormonal Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Menopause Hormonal Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Menopause Hormonal Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Menopause Hormonal Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Menopause Hormonal Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Menopause Hormonal Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Menopause Hormonal Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Menopause Hormonal Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Menopause Hormonal Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Menopause Hormonal Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Menopause Hormonal Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Menopause Hormonal Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Menopause Hormonal Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Menopause Hormonal Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Menopause Hormonal Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Menopause Hormonal Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Menopause Hormonal Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Menopause Hormonal Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Menopause Hormonal Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Menopause Hormonal Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Menopause Hormonal Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Menopause Hormonal Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Menopause Hormonal Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Menopause Hormonal Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Menopause Hormonal Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Menopause Hormonal Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Menopause Hormonal Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Menopause Hormonal Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Menopause Hormonal Drug Raw Material
Table 121. Key Manufacturers of Menopause Hormonal Drug Raw Materials
Table 122. Menopause Hormonal Drug Typical Distributors
Table 123. Menopause Hormonal Drug Typical Customers
List of Figures
Figure 1. Menopause Hormonal Drug Picture
Figure 2. Global Menopause Hormonal Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Menopause Hormonal Drug Consumption Value Market Share by Type in 2022
Figure 4. Table Examples
Figure 5. Gel Examples
Figure 6. Spray Examples
Figure 7. Others Examples
Figure 8. Global Menopause Hormonal Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Menopause Hormonal Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Pharmacies Examples
Figure 11. Retail Pharmacies Examples
Figure 12. Online Pharmacies Examples
Figure 13. Global Menopause Hormonal Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Menopause Hormonal Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Menopause Hormonal Drug Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Menopause Hormonal Drug Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Menopause Hormonal Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Menopause Hormonal Drug Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Menopause Hormonal Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Menopause Hormonal Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Menopause Hormonal Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Menopause Hormonal Drug Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Menopause Hormonal Drug Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Menopause Hormonal Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Menopause Hormonal Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Menopause Hormonal Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Menopause Hormonal Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Menopause Hormonal Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Menopause Hormonal Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Menopause Hormonal Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Menopause Hormonal Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Menopause Hormonal Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Menopause Hormonal Drug Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Menopause Hormonal Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Menopause Hormonal Drug Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Menopause Hormonal Drug Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Menopause Hormonal Drug Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Menopause Hormonal Drug Consumption Value Market Share by Region (2018-2029)
Figure 55. China Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Menopause Hormonal Drug Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Menopause Hormonal Drug Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Menopause Hormonal Drug Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Menopause Hormonal Drug Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Menopause Hormonal Drug Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Menopause Hormonal Drug Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Menopause Hormonal Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Menopause Hormonal Drug Market Drivers
Figure 76. Menopause Hormonal Drug Market Restraints
Figure 77. Menopause Hormonal Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Menopause Hormonal Drug in 2022
Figure 80. Manufacturing Process Analysis of Menopause Hormonal Drug
Figure 81. Menopause Hormonal Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の基底細胞癌治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の薬物吸入器市場2023年：企業・地域・タイプ・用途別分析
  • 世界のインテリジェント静脈薬剤調剤ロボット市場2023年：企業・地域・タイプ・用途別分析
  • 世界のカルシニューリン阻害薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の薬物検出迅速検査キット市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23JU620 )"世界の更年期ホルモン剤市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Menopause Hormonal Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。